{
     "PMID": "12706464",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20031202",
     "LR": "20131121",
     "IS": "0014-2999 (Print) 0014-2999 (Linking)",
     "VI": "467",
     "IP": "1-3",
     "DP": "2003 Apr 25",
     "TI": "Inhibition of high K+-evoked gamma-aminobutyric acid release by sodium nitroprusside in rat hippocampus.",
     "PG": "119-23",
     "AB": "To clarify whether nitric oxide (NO) modifies high K(+)-evoked gamma-aminobutyric acid (GABA) release, we examined the effects of sodium nitroprusside, an NO donor; diethyldithiocarbamate, an NO trapper; dithiothreitol, a superoxide radical scavenger; and 1H-(1,2,4)oxadiazole(4,3-a)quinoxalin-1-one, a specific guanylyl cyclase inhibitor, on high (100 mM) K(+)-evoked GABA release from rat hippocampus in vivo using microdialysis. Perfusion with 0.5 or 5 mM sodium nitroprusside significantly reduced high K(+)-evoked GABA release. Co-perfusion with 0.5 mM sodium nitroprusside and 5 mM diethyldithiocarbamate or 0.5 mM 1H-(1,2,4)oxadiazole(4,3-a)quinoxalin-1-one significantly enhanced high K(+)-evoked GABA release. Co-perfusion with 0.5 mM sodium nitroprusside and 1 mM dithiothreitol tended to increase it. These results demonstrate that sodium nitroprusside reduces high K(+)-evoked GABA release both via an NO/cyclic GMP-dependent pathway and via an NO-dependent, but cyclic GMP-independent, pathway in rat hippocampus in vivo.",
     "FAU": [
          "Hada, Junichi",
          "Kaku, Tomohiro",
          "Jiang, Min Hai",
          "Morimoto, Kazuyoshi",
          "Hayashi, Yasamasa"
     ],
     "AU": [
          "Hada J",
          "Kaku T",
          "Jiang MH",
          "Morimoto K",
          "Hayashi Y"
     ],
     "AD": "Department of Medical Physics and Chemistry, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo, 663-8501, Japan. jhada@hyo-med.ac.jp",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "PL": "Netherlands",
     "TA": "Eur J Pharmacol",
     "JT": "European journal of pharmacology",
     "JID": "1254354",
     "RN": [
          "0 (1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one)",
          "0 (Free Radical Scavengers)",
          "0 (Nitric Oxide Donors)",
          "0 (Oxadiazoles)",
          "0 (Quinoxalines)",
          "169D1260KM (Nitroprusside)",
          "31C4KY9ESH (Nitric Oxide)",
          "56-12-2 (gamma-Aminobutyric Acid)",
          "99Z2744345 (Ditiocarb)",
          "EC 4.6.1.2 (Guanylate Cyclase)",
          "RWP5GA015D (Potassium)",
          "T8ID5YZU6Y (Dithiothreitol)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Dithiothreitol/pharmacology",
          "Ditiocarb/pharmacology",
          "Free Radical Scavengers/pharmacology",
          "Guanylate Cyclase/antagonists & inhibitors",
          "Hippocampus/drug effects/*metabolism",
          "Male",
          "Microdialysis",
          "Nitric Oxide/*physiology",
          "Nitric Oxide Donors/*pharmacology",
          "Nitroprusside/*pharmacology",
          "Oxadiazoles/pharmacology",
          "Potassium/*pharmacology",
          "Quinoxalines/pharmacology",
          "Rats",
          "Rats, Wistar",
          "gamma-Aminobutyric Acid/*metabolism"
     ],
     "EDAT": "2003/04/23 05:00",
     "MHDA": "2003/12/03 05:00",
     "CRDT": [
          "2003/04/23 05:00"
     ],
     "PHST": [
          "2003/04/23 05:00 [pubmed]",
          "2003/12/03 05:00 [medline]",
          "2003/04/23 05:00 [entrez]"
     ],
     "AID": [
          "S0014299903016054 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Eur J Pharmacol. 2003 Apr 25;467(1-3):119-23.",
     "term": "hippocampus"
}